Turmeric Acquisition Corp. (TMPM) Stock Analysis
DELISTED 2022
What happened to Turmeric Acquisition Corp. (TMPM) stock?
Turmeric Acquisition Corp. (TMPM) no longer trades on public markets. It was delisted in October 2022. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Turmeric Acquisition Corp. (TMPM) trades at $10.03. Turmeric Acquisition Corp. is a shell company focused on merging with or acquiring a business in the healthcare sector. Sector: Financial services.
Last analyzed: Mar 18, 2026Analyst Coverage for TMPM: TMPM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TMPM against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Turmeric Acquisition Corp. (TMPM) Financial Services Profile
Turmeric Acquisition Corp., a shell company, seeks a merger or acquisition within the healthcare industry. Incorporated in 2020, the company aims to capitalize on opportunities within the healthcare sector, but currently lacks operational activity, distinguishing it from established healthcare operators and specialized financial firms.
What Is the Investment Thesis for TMPM?
Turmeric Acquisition Corp. presents a speculative investment opportunity, contingent on its ability to identify and successfully merge with a viable healthcare business. The company's value is primarily derived from its potential to execute a successful acquisition, which is inherently uncertain. With a P/E ratio of 18.97, the valuation reflects market expectations of a future transaction. Key catalysts include the announcement of a merger target and the subsequent completion of the acquisition. However, potential risks include the failure to identify a suitable target, regulatory hurdles, and market volatility impacting the valuation of the acquired entity.
Based on FMP financials and quantitative analysis
TMPM Key Highlights
Turmeric Acquisition Corp. operates as a shell company, focusing on mergers and acquisitions within the healthcare sector.
- The company was incorporated in 2020 and is based in Cambridge, Massachusetts.
- Turmeric Acquisition Corp. is a subsidiary of Turmeric Management, LLC.
- The company's P/E ratio is 18.97, reflecting market expectations of a future transaction.
- Turmeric Acquisition Corp. does not offer a dividend.
Who Are TMPM's Competitors?
TMPM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ACAH Atlantic Coastal Acquisition Corp. | $10.45 | -1.69% | $127M | 44 |
| BMAC Black Mountain Acquisition Corp. | $10.56 | -0.38% | $131M | 44 |
| FZT FAST Acquisition Corp. II | $7.76 | -30.90% | $98.5M | 46 |
| LFAC Leapfrog Acquisition Corporation | $10.07 | +0.25% | $193M | 64 |
| NNAG 99 Acquisition Group Inc. Class A Common Stock | $10.55 | -0.19% | $133M | 44 |
| AGGI Allied Energy, Inc. | $2.25 | +32.24% | $45.4B | 61 |
| GSHN Gushen, Inc. | $22.70 | +2.71% | $9.32B | 61 |
| IVAN Ivanhoe Capital Acquisition Corp. | $7.68 | -2.17% | $2.69B | 64 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TMPM's Key Strengths?
Experienced management team with healthcare expertise.
- Access to capital markets for funding acquisitions.
- Clear focus on the healthcare sector.
- Flexibility to pursue various types of business combinations.
What Are TMPM's Weaknesses?
Lack of operating history and revenue generation.
- Dependence on identifying and completing a successful acquisition.
- Intense competition from other SPACs.
- Potential for conflicts of interest with management.
What Could Drive TMPM Stock Higher?
Announcement of a definitive agreement to acquire a healthcare business.
- Progress in negotiations with potential acquisition targets.
- Favorable market conditions for healthcare investments.
What Are the Key Risks for TMPM?
Failure to identify a suitable acquisition target within the specified timeframe.
- Regulatory challenges and delays in obtaining necessary approvals.
- Market volatility impacting the valuation of the acquired business.
- Intense competition from other SPACs seeking acquisition opportunities.
- Changes in healthcare policy and reimbursement rates affecting the target company.
What Are the Growth Opportunities for TMPM?
- Acquisition of a High-Growth Healthcare Company: Turmeric Acquisition Corp.'s primary growth opportunity lies in acquiring a high-growth healthcare company with strong market potential. The timeline for this growth opportunity is dependent on the company's ability to identify and complete a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
- Strategic Partnerships: Turmeric Acquisition Corp. can pursue strategic partnerships with established healthcare companies to enhance its deal-sourcing capabilities and industry expertise. These partnerships could provide access to proprietary deal flow and insights into emerging trends within the healthcare sector. The timeline for establishing strategic partnerships is dependent on the company's ability to cultivate relationships with key industry players and negotiate mutually beneficial agreements.
- Expansion into Adjacent Healthcare Verticals: Turmeric Acquisition Corp. can explore opportunities to expand into adjacent healthcare verticals, such as digital health, telehealth, and personalized medicine. These verticals are experiencing rapid growth and offer attractive investment opportunities for SPACs. The timeline for expanding into adjacent healthcare verticals is dependent on the company's ability to identify and acquire businesses with innovative technologies and strong market positions.
- Geographic Expansion: Turmeric Acquisition Corp. can consider geographic expansion into international markets with high growth potential in the healthcare sector. Emerging markets, such as Asia and Latin America, offer attractive investment opportunities for SPACs seeking to capitalize on the increasing demand for healthcare services. The timeline for geographic expansion is dependent on the company's ability to navigate regulatory complexities and establish a presence in foreign markets.
- Leveraging Technological Advancements: Turmeric Acquisition Corp. can leverage technological advancements, such as artificial intelligence and machine learning, to identify and evaluate potential acquisition targets. These technologies can help the company analyze large datasets and identify businesses with strong growth potential and competitive advantages. The timeline for leveraging technological advancements is dependent on the company's ability to integrate these technologies into its deal-sourcing and due diligence processes.
What Opportunities Does TMPM Have?
- Growing demand for healthcare services and technologies.
- Increasing number of private healthcare companies seeking to go public.
- Potential for consolidation within the healthcare industry.
- Favorable regulatory environment for healthcare innovation.
What Are TMPM's Competitive Advantages?
- Access to capital markets for funding acquisitions.
- Management team's experience in healthcare investing.
- Network of relationships within the healthcare industry.
What Does TMPM Do?
Turmeric Acquisition Corp., incorporated in 2020 and based in Cambridge, Massachusetts, operates as a special purpose acquisition company (SPAC). As a shell company, Turmeric Acquisition Corp. does not have significant operations of its own. Its primary focus is to identify and complete a business combination, such as a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more businesses or entities. The company's stated intention is to target businesses within the healthcare or healthcare-related industries. Turmeric Acquisition Corp. is a subsidiary of Turmeric Management, LLC. The company's strategy revolves around leveraging the expertise and network of its management team to identify a suitable target company in the healthcare sector. Upon identifying a target, Turmeric Acquisition Corp. would seek to raise capital through public and private offerings to finance the acquisition. The success of Turmeric Acquisition Corp. depends on its ability to identify and acquire a promising healthcare business and to successfully integrate it into the public market.
What Products and Services Does TMPM Offer?
- Focuses on effecting a merger with a healthcare-related business.
- Pursues share exchange opportunities within the healthcare sector.
- Considers asset acquisitions in the healthcare industry.
- Evaluates share purchase options with healthcare companies.
- Explores reorganization opportunities within the healthcare sector.
- Seeks a business combination with one or more healthcare entities.
How Does TMPM Make Money?
- Identifies and evaluates potential acquisition targets in the healthcare industry.
- Negotiates and executes a business combination transaction.
- Raises capital through public and private offerings to finance the acquisition.
- Integrates the acquired business into the public market.
What Industry Does TMPM Operate In?
Turmeric Acquisition Corp. operates within the shell company industry, specifically targeting the healthcare sector for potential acquisitions. The SPAC market has experienced periods of heightened activity and increased scrutiny. The success of SPACs like Turmeric Acquisition Corp. depends on their ability to identify attractive targets and navigate the regulatory landscape. Competition within the SPAC market is intense, with numerous SPACs vying for acquisition opportunities. Market trends, such as the increasing demand for healthcare services and technological advancements in the healthcare industry, may influence the types of targets that SPACs pursue.
Who Are TMPM's Key Customers?
- Not applicable, as the company is a shell corporation seeking a target company.
Company Profile
Turmeric Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Cambridge, US. TMPM has traded publicly since 2020.
Key Financial Metrics
Return on equity for Turmeric Acquisition Corp. stands at 14.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.8%, showing how much profit it generates from its asset base. TMPM trades at a trailing price-to-earnings ratio of 18.97, roughly in line with the Financial Services sector average of ~18x. A current ratio of 0.95 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 5.3%, the inverse of the P/E and a quick read on earnings relative to price.
Insider Activity
The most recent 10 insider filings for Turmeric Acquisition Corp. break down as 6 sales and 4 purchases. On net that is roughly 1.6M shares disposed (about $8.3M), a signal worth weighing alongside the fundamentals.
TMPM Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Experienced management team with healthcare expertise.
- Access to capital markets for funding acquisitions.
- Clear focus on the healthcare sector.
- Flexibility to pursue various types of business combinations.
Bear Case
- Lack of operating history and revenue generation.
- Dependence on identifying and completing a successful acquisition.
- Intense competition from other SPACs.
- Potential for conflicts of interest with management.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
TMPM Latest News
No recent news available for TMPM.
Classification
Industry Shell CompaniesTMPM Financial Services Stock FAQ
What happened to Turmeric Acquisition Corp. (TMPM) stock?
Turmeric Acquisition Corp. (TMPM) no longer trades on public markets. It was delisted in October 2022. The figures below are historical and are not a current quote.
Can I still buy TMPM shares?
No. TMPM stopped trading on public markets in October 2022, so the shares are not available through a broker. Anything you see quoted for TMPM elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before TMPM stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Turmeric Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Turmeric Acquisition Corp. do?
Turmeric Acquisition Corp. is a special purpose acquisition company (SPAC), also known as a blank check company. It was formed with the sole purpose of raising capital through an initial public offering (IPO) to acquire an existing private company, primarily in the healthcare sector. It does not have any operations of its own. After identifying a target, Turmeric Acquisition Corp.
What do analysts say about TMPM stock?
As of March 18, 2026, there is no readily available analyst consensus on Turmeric Acquisition Corp. (TMPM) due to its nature as a shell company. The stock's valuation is primarily driven by the potential of a future merger or acquisition. Investors should closely monitor the company's progress in identifying and securing a target company in the healthcare sector.
What are the main risks for TMPM?
The primary risk for Turmeric Acquisition Corp. is the failure to identify and complete a suitable acquisition within a reasonable timeframe, which could lead to the liquidation of the company and the return of capital to shareholders. Other risks include regulatory hurdles, market volatility impacting the valuation of potential targets, and competition from other SPACs.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- The company's future performance is highly dependent on its ability to complete a successful acquisition.